SCHEMBL4236544

SCHEMBL4236544

NS(=O)(=O)S(=O)(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL27613221 0.88 CA1 (0.50)
SCHEMBL28898384 0.79 CA1 (0.50)
Sulfamate SCHEMBL11400 0.78
Sulfamate SCHEMBL2545884 0.78 CA1 (1.00)
Sulfamate SCHEMBL285371 0.78
Sulfamate SCHEMBL23581784 0.74
Sulfamate SCHEMBL11115704 0.74
Sulfamate SCHEMBL3145080 0.74
Sulfamate SCHEMBL20658932 0.74
Sulfamate SCHEMBL21641875 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1984372-B1 ORGANIC COMPOUND, ANISOTROPIC OPTICAL FILM AND METHOD OF PRODUCTION THEREOF CRYSOPTIX KK (JP) 2009-07-22 EP claimed
CN-101336225-A Alkylation of n' -phenyl-n-alkylphenylenediamines in ionic liquid, n' -phenyl-n-alkyl(alkylphenylene) diamines produced thereby, and lubricant compositions containing same CHEMTURA CORP (US) 2008-12-31 CN claimed
CN-100339389-C Hepatitis C tripeptide inhibitors BOEHRINGER INGELHEIM CA LTD (CA) 2007-09-26 CN claimed
US-20070135399-A1 Heteroaromatic sulphonamide prodrugs BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-06-14 US claimed
JP-2002539247-A 2002-11-19 JP claimed
EP-1162970-A2 ANTI-INFLAMMATORY USES OF MANZAMINES HARBOR BRANCH OCEANOGRAPHIC INSTITUTION, INC. (US) 2001-12-19 EP claimed
WO-2000056304-A2 ANTI-INFLAMMATORY USES OF MANZAMINES HARBOR BRANCH OCEANOGRAPHIC INSTITUTION, INC. (US) 2000-09-28 WO claimed
US-5075323-A Reducing intraocular pressure AKTIEBOLAGET HASSLE (SE) 1991-12-24 US claimed
WO-1990002124-A1 TREATMENT OF GLAUCOMA AND RELATED DISORDERS IN THE HUMAN EYE WITH PYRIDINYLMETHYL (SULFINYL OR THIO)BENZIMIDAZOLES Aktiebolaget Hässle (SE) 1990-03-08 WO claimed
EP-0332647-A1 NEW BENZIMIDAZOLE DERIVATIVES A PROCESS FOR PRODUCTION THEREOF AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME Aktiebolaget Hässle (SE) 1989-09-20 EP claimed
WO-1989003830-A1 2-PYRIDINYLMETHYL (SULFINYL OR THIO)BENZIMIDAZOLES FOR TREATMENT OF DISEASES RELATED TO BONE LOSS Aktiebolaget Hässle (SE) 1989-05-05 WO claimed
WO-1988003921-A1 NEW BENZIMIDAZOLE DERIVATIVES A PROCESS FOR PRODUCTION THEREOF AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME Aktiebolaget Hässle (SE) 1988-06-02 WO claimed
JP-11209152-A None JP disclosed
CN-122055354-A Lipid compounds and related compositions and uses 波西达治疗公司 2026-05-15 CN disclosed
CN-115916142-A Coupled terpene conjugates 埃里格实验室公司 2023-04-04 CN disclosed
CN-110300521-B Fungicidal compositions 先正达参股股份有限公司 2021-10-15 CN disclosed
US-20020137655-A1 Use of haloperoxidase, peroxide and carboxylic acid NOVOZYMES A/S (DK) 2002-09-26 US disclosed
JP-H11209152-A CEMENT ADMIXTURE AND CEMENT COMPOSITION CONTAINING THE SAME DENKI KAGAKU KOGYO KK 1999-08-03 JP disclosed
EP-0338066-A1 2-PYRIDINYLMETHYL (SULFINYL OR THIO)BENZIMIDAZOLES FOR TREATMENT OF DISEASES RELATED TO BONE LOSS Aktiebolaget Hässle (SE) 1989-10-25 EP disclosed
WO-1989003830-A1 2-PYRIDINYLMETHYL (SULFINYL OR THIO)BENZIMIDAZOLES FOR TREATMENT OF DISEASES RELATED TO BONE LOSS Aktiebolaget Hässle (SE) 1989-05-05 WO disclosed